Skip NavigationSkip to Content

Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore

  1. Author:
    McNulty, J.
    Mao, J.
    Gibe, R.
    Mo, R. W.
    Wolf, S.
    Pettit, G. R.
    Herald, D. L.
    Boyd, M. R.
  2. Author Address

    Brock Univ, Dept Chem, Inst Mol Catalysis, St Catharines, ON L2S 3A1, Canada. Brock Univ, Dept Chem, Inst Mol Catalysis, St Catharines, ON L2S 3A1, Canada. Arizona State Univ, Canc Res Inst, Tempe, AZ 85287 USA. Arizona State Univ, Dept Chem, Tempe, AZ 85287 USA. NCI, Lab Drug Discovery Res & Dev, Div Basic Sci, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA. McNulty J Brock Univ, Dept Chem, Inst Mol Catalysis, St Catharines, ON L2S 3A1, Canada.
    1. Year: 2001
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 11
    2. 2
    3. Pages: 169-172
  2. Type of Article: Article
  1. Abstract:

    Two deoxy-analogues of the anticancer/antiviral agent pancratistatin containing functionality complementary to the minimum structural pharmacophore were synthesized and subjected to anticancer screening. One of the analogues exhibited selective inhibition of certain tumor cell lines but was significantly less potent than the natural products. The minimum structural pharmacophore has now been refined from eight to three possible structures. (C) 2001 Elsevier Science Ltd. All rights reserved.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel